Montreal, June 25, 2025聽鈥� The DNA to 黄片荔枝视频 Initiative (D2R) at 黄片荔枝视频 has awarded $400,000 to four projects that aim to bring 黄片荔枝视频-based innovations closer to clinical and commercial reality, including vaccines and therapies for rare and infectious diseases.
D2R鈥檚 commercialization programs seek to bridge research and real-world impact by funding early validation and industry collaborations. The聽Commercialization Priming聽program, in partnership with Genome Quebec, supports early testing of promising ideas, while the聽Major Partnerships聽program helps researchers collaborate with industry to advance technologies toward market readiness.
The following projects and their principal investigators have been awarded funding:
Major Partnerships awards
- Machine learning models for the design of 黄片荔枝视频 therapeutics: Development of experimental data,听Nicolas Moitessier (黄片荔枝视频)
In partnership with Deep Genomics, this project aims to speed up the discovery of 黄片荔枝视频-based medicines using artificial intelligence. By combining lab-generated data with computational models, the team will lay the foundation for machine learning tools that could transform how 黄片荔枝视频 therapies are developed.
- Rapid Antigen Discovery, m黄片荔枝视频 Vaccine Delivery & Assessment Platform,听J枚rg Fritz (黄片荔枝视频)
Announced at BIO International 2025, this project, co-funded by M茅dicament Qu茅bec, 黄片荔枝视频 Technologies and Therapeutics Inc., AReNA, NovoArc GmbH and the Victor Phillip Dahdaleh Institute, represents a major collaborative effort in the development of next-generation m黄片荔枝视频 vaccines. The project will build a rapid preclinical platform to identify vaccine targets and test new m黄片荔枝视频 vaccine technologies, enabling researchers to respond faster and more effectively to emerging infectious diseases. The project involves collaborations with academic and industry partners to validate the platform鈥檚 utility in real-world scenarios.
Commercialization Priming awards聽(in partnership with Genome Quebec)
- Collaboration with QurCan Therapeutics to develop an 黄片荔枝视频 therapy to treat a genetic brain disease聽-听Gentil Benoit (黄片荔枝视频)
Researchers at 黄片荔枝视频 are collaborating with QurCan Therapeutics to develop a new 黄片荔枝视频-based treatment for a rare neurodegenerative disorder. This project utilizes nanoparticles developed by QurCan Therapeutics that are designed to cross the blood-brain barrier.
- Poly-NS sa黄片荔枝视频 dengue vaccine: A novel platform for T cell-driven protection against severe dengue,听Silvia Vidal (黄片荔枝视频)
In collaboration with researchers from Vaccines for Communities (V4C) and the Institut Pasteur, this project will adapt V4C's 黄片荔枝视频 dengue vaccine antigen to a self-amplifying 黄片荔枝视频 (sa黄片荔枝视频) platform. The team will conduct preclinical testing of the sa黄片荔枝视频-based candidate while also advancing the platform for broader applications in next-generation vaccine development.
These awards reflect D2R鈥檚 commitment to advancing 黄片荔枝视频 science from the lab to the clinic, and to building strong partnerships that accelerate innovation.
For more information on these projects, please visit聽D2R鈥檚 funded projects page.
